| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 156, Issue 10 3892-3900, Copyright © 1996 by American Association of Immunologists
ARTICLES |
S Tamura, K Miyata, K Matsuo, H Asanuma, H Takahashi, K Nakajima, Y Suzuki, C Aizawa and T Kurata
Department of Pathology, National Institute of Health, Tokyo, Japan.
The protective roles of influenza viral nucleoprotein (NP), together with the cellular mechanism of the protection in the nasal site, were examined in BALB/c mice immunized intranasally with an adjuvant (cholera toxin B subunit containing 0.2% of the whole toxin)-combined A or B virus recombinant NP. The NP-immune mice, when challenged intranasally with a sublethal dose of the virus 3 wk after immunization, had accelerated virus clearance from the nasal site in both an influenza type-specific and a nonspecific manner, as shown by the protection from high morbidity from the second day after challenge. Both type-specific and nonspecific acceleration of recovery was confirmed by the increased survival rate after challenge with a lethal dose of virus in mice immunized and boosted with adjuvant-combined NP. The acceleration of nasal virus clearance was accompanied with acceleration of type-specific systemic delayed-type hypersensitivity (DTH) and with IFN-gamma production by nasal lymphocytes. The nasal lymphocytes from the immunized and challenged mice generated a significantly high level of DTH when transferred locally, but no class I MHC-restricted CTL response. Moreover, nasal CD4+ T cells, induced by NP immunization and increased in number by the subsequent challenge, were involved in the accelerated IFN-gamma production. These results suggest that nasal Th1 cells, capable of producing IFN-gamma and mediating DTH, are involved in the type-specific acceleration of recovery from influenza after challenge in mice immunized intranasally with adjuvant-combined NP, although the nonspecific mechanism of accelerated recovery remains to be solved.
This article has been cited by other articles:
|
|
 |
|
  D. M. Jelley-Gibbs, J. P. Dibble, D. M. Brown, T. M. Strutt, K. K. McKinstry, and S. L. Swain Persistent Depots of Influenza Antigen Fail To Induce a Cytotoxic CD8 T Cell Response J. Immunol., June 15, 2007; 178(12): 7563 - 7570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hagiwara, Y. I. Kawamura, K. Kataoka, B. Rahima, R. J. Jackson, K. Komase, T. Dohi, P. N. Boyaka, Y. Takeda, H. Kiyono, et al. A Second Generation of Double Mutant Cholera Toxin Adjuvants: Enhanced Immunity without Intracellular Trafficking. J. Immunol., September 1, 2006; 177(5): 3045 - 3054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ichinohe, I. Watanabe, S. Ito, H. Fujii, M. Moriyama, S.-i. Tamura, H. Takahashi, H. Sawa, J. Chiba, T. Kurata, et al. Synthetic Double-Stranded RNA Poly(I:C) Combined with Mucosal Vaccine Protects against Influenza Virus Infection J. Virol., March 1, 2005; 79(5): 2910 - 2919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Crowe, S. C. Miller, R. M. Shenyo, and D. L. Woodland Vaccination with an Acidic Polymerase Epitope of Influenza Virus Elicits a Potent Antiviral T Cell Response but Delayed Clearance of an Influenza Virus Challenge J. Immunol., January 15, 2005; 174(2): 696 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yoshikawa, K. Matsuo, K. Matsuo, Y. Suzuki, A. Nomoto, S.-i. Tamura, T. Kurata, and T. Sata Total viral genome copies and virus-Ig complexes after infection with influenza virus in the nasal secretions of immunized mice J. Gen. Virol., August 1, 2004; 85(8): 2339 - 2346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yasui, J. Kiyoshima, and T. Hori Reduction of Influenza Virus Titer and Protection against Influenza Virus Infection in Infant Mice Fed Lactobacillus casei Shirota Clin. Vaccine Immunol., July 1, 2004; 11(4): 675 - 679. [Abstract] [Full Text]
|
|
|
|
|
|
K. Kataoka, J. R. McGhee, R. Kobayashi, K. Fujihashi, S. Shizukuishi, and K. Fujihashi Nasal Flt3 Ligand cDNA Elicits CD11c+CD8+ Dendritic Cells for Enhanced Mucosal Immunity J. Immunol., March 15, 2004; 172(6): 3612 - 3619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hagiwara, J. R. McGhee, K. Fujihashi, R. Kobayashi, N. Yoshino, K. Kataoka, Y. Etani, M.-N. Kweon, S. Tamura, T. Kurata, et al. Protective Mucosal Immunity in Aging Is Associated with Functional CD4+ T Cells in Nasopharyngeal-Associated Lymphoreticular Tissue J. Immunol., February 15, 2003; 170(4): 1754 - 1762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mizuki, A. Nakane, K. Sekikawa, Y.-i. Tagawa, and Y. Iwakura Comparison of Host Resistance to Primary and Secondary Listeria monocytogenes Infections in Mice by Intranasal and Intravenous Routes Infect. Immun., September 1, 2002; 70(9): 4805 - 4811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Guy Evaluation of Events Occurring at Mucosal Surfaces: Techniques Used To Collect and Analyze Mucosal Secretions and Cells Clin. Vaccine Immunol., July 1, 2002; 9(4): 753 - 762. [Full Text] [PDF]
|
|
|
|
|
|
Y. Asahi, T. Yoshikawa, I. Watanabe, T. Iwasaki, H. Hasegawa, Y. Sato, S.-i. Shimada, M. Nanno, Y. Matsuoka, M. Ohwaki, et al. Protection Against Influenza Virus Infection in Polymeric Ig Receptor Knockout Mice Immunized Intranasally with Adjuvant-Combined Vaccines J. Immunol., March 15, 2002; 168(6): 2930 - 2938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Dercamp, V. Sanchez, J. Barrier, E. Trannoy, and B. Guy Depletion of Human NK and CD8 Cells prior to In Vitro H1N1 Flu Vaccine Stimulation Increases the Number of Gamma Interferon-Secreting Cells Compared to the Initial Undepleted Population in an ELISPOT Assay Clin. Vaccine Immunol., March 1, 2002; 9(2): 230 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hori, J. Kiyoshima, K. Shida, and H. Yasui Augmentation of Cellular Immunity and Reduction of Influenza Virus Titer in Aged Mice Fed Lactobacillus casei Strain Shirota Clin. Vaccine Immunol., January 1, 2002; 9(1): 105 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Tumpey, M. Renshaw, J. D. Clements, and J. M. Katz Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection against Lethal Influenza A H5N1 Virus Infection J. Virol., June 1, 2001; 75(11): 5141 - 5150. [Abstract] [Full Text]
|
|
|
|
|
|
T. Hori, J. Kiyoshima, K. Shida, and H. Yasui Effect of Intranasal Administration of Lactobacillus casei Shirota on Influenza Virus Infection of Upper Respiratory Tract in Mice Clin. Vaccine Immunol., May 1, 2001; 8(3): 593 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Hodge, M. Marinaro, H. P. Jones, J. R. McGhee, H. Kiyono, and J. W. Simecka Immunoglobulin A (IgA) Responses and IgE-Associated Inflammation along the Respiratory Tract after Mucosal but Not Systemic Immunization Infect. Immun., April 1, 2001; 69(4): 2328 - 2338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kodama, S. Suenaga, T. Hirano, M. Suzuki, and G. Mogi Induction of Specific Immunoglobulin A and Th2 Immune Responses to P6 Outer Membrane Protein of Nontypeable Haemophilus influenzae in Middle Ear Mucosa by Intranasal Immunization Infect. Immun., April 1, 2000; 68(4): 2294 - 2300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Chen, T. Yoshikawa, S.-e. Kadowaki, Y. Hagiwara, K. Matsuo, H. Asanuma, C. Aizawa, T. Kurata, and S.-i. Tamura Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein J. Gen. Virol., October 1, 1999; 80(10): 2559 - 2564. [Abstract] [Full Text]
|
|
|
|
|
|
T. Fukuizumi, H. Inoue, T. Tsujisawa, and C. Uchiyama Tonsillar Application of Formalin-Killed Cells of Streptococcus sobrinus Reduces Experimental Dental Caries in Rabbits Infect. Immun., January 1, 1999; 67(1): 426 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Matousek, J. G. Nedrud, W. Cieplak Jr., and C. V. Harding Inhibition of Class II Major Histocompatibility Complex Antigen Processing by Escherichia coli Heat-Labile Enterotoxin Requires an Enzymatically Active A Subunit Infect. Immun., July 1, 1998; 66(7): 3480 - 3484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Tamura, T Iwasaki, A. Thompson, H Asanuma, Z Chen, Y Suzuki, C Aizawa, and T Kurata Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection J. Gen. Virol., February 1, 1998; 79(2): 291 - 299. [Abstract]
|
|
|
|
 |
|
 P. L. HERITAGE, B. J. UNDERDOWN, A. L. ARSENAULT, D. P. SNIDER, and M. R. MCDERMOTT Comparison of Murine Nasal-associated Lymphoid Tissue and Peyer's Patches Am. J. Respir. Crit. Care Med., October 1, 1997; 156(4): 1256 - 1262. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
